Estradiol-dependent perforin expression by human regulatory T-cells

European Journal of Clinical Investigation

Volumn 41, Issue 4, 2011, Pages 357-364

  Valor, Larissa ^a   Teijeiro, Roseta ^a   Aristimuño, Carol ^a   Faure, Florence ^b   Alonso, Bárbara ^a   de Andrés, Clara ^a   Tejera, Marta ^a   López Lazareno, Nieves ^a   Fernández Cruz, Eduardo ^a   Sánchez Ramón, Silvia ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b PSL RESEARCH UNIVERSITY   (France)

Author keywords

Immunoregulation; Intracellular perforin expression; Regulatory T cells

Indexed keywords

CELL MARKER; ESTRADIOL; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; PERFORIN; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOTOXICITY; DATA ANALYSIS; DEGRANULATION; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOREGULATION; MEDICAL RECORD; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ADULT; ANIMALS; ESTRADIOL; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GRANZYMES; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PERFORIN; PREGNANCY; RECEPTORS, ANTIGEN, T-CELL; STATISTICS AS TOPIC; T-LYMPHOCYTES, REGULATORY;

EID: 79952519419     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02414.x     Document Type: Article

References (32)

1. Sakaguchi S. Control of immune responses by naturally arising CD4+ regulatory T cells that express toll-like receptors. J Exp Med 2003;197:397-401.
2. Shevach EM, Piccirillo CA, Thornton AM, McHugh RS. Control of T cell activation by CD4+CD25+ suppressor T cells. Novartis Found Symp 2003;252:24-36; discussion -44, 106-14.
3. Schwartz M, Kipnis J. Autoimmunity on alert: naturally occurring regulatory CD4(+)CD25(+) T cells as part of the evolutionary compromise between a 'need' and a 'risk'. Trends Immunol 2002;23:530-4.
4. Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007;445:771-5.
5. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998;10:1969-80.
6. Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells invitro and actively inhibit their maturation. Proc Natl Acad Sci USA 2008;105:10113-8.
7. Shevach EM, DiPaolo RA, Andersson J, Zhao DM, Stephens GL, Thornton AM. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev 2006;212:60-73.
8. Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005;174:1783-6.
9. Cao W, Liu YJ. Innate immune functions of plasmacytoid dendritic cells. Curr Opin Immunol 2007;19:24-30.
10. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004;21:589-601.
11. Aziz KE, McCluskey PJ, Wakefield D. Expression of selectins (CD62 E, L, P) and cellular adhesion molecules in primary Sjogren's syndrome: questions to immunoregulation. Clin Immunol Immunopathol 1996;80:55-66.
12. Peters PJ, Borst J, Oorschot V, Fukuda M, Krahenbuhl O, Tschopp J et al. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 1991;173:1099-109.
13. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004;5:266-71.
14. Prieto GA, Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology 2006;118:58-65.
15. Aristimuño C, De Andrés C, Alvarez A, Roncador G, Navarro J, Rodríguez-Sáinz MC et al. Sex-linked dimorphism for regulatory T-lymphocytes may be relevant in multiple sclerosis. Mult Scler 2005;11(Suppl 5):S128.
16. Polanczyk MJ, Hopke C, Huan J, Vandenbark AA, Offner H. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J Neuroimmunol 2005;170:85-92.
17. Arruvito L, Sanz M, Banham AH, Fainboim L. Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol 2007;178:2572-8.
18. Amsalem H, Gaiger A, Mizrahi S, Yagel S, Rachmilewitz J. Characterization of a lymphocyte subset displaying a unique regulatory activity in human decidua. Int Immunol 2008;20:1147-54.
19. Sánchez-Ramón S, Navarro AJ, Aristimuño C, Rodriguez-Mahou M, Bellon JM, Fernández-Cruz E et al. Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity. Immunol Lett 2005;96:195-201.
20. Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler SF et al. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol 2004;173:2227-30.
21. Sánchez-Ramón S, Bellon JM, Resino S, Cantó-Nogués C, Gurbindo D, Ramos JT et al. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children. Pediatrics 2003;111:E168-75.
22. De Andrés C, Aristimuño C, de Las Heras V, Martinez-Gines ML, Bartolome M, Arroyo R et al. Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis. J Neuroimmunol 2007;182:204-11.
23. De Andrés C, Aristimuño C, Bartolome M, de Las Heras V, Martinez-Gines ML, Arroyo R et al. Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells differential role of circulating dendritic cells and CD4(+) regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year longitudinal study. J Neuroimmunol 2007;182:204-11.
24. Mjosberg J, Svensson J, Johansson E, Hellstrom L, Casas R, Jenmalm MC et al. Systemic reduction of functionally suppressive CD4dimCD25highFoxp3+ Tregs in human second trimester pregnancy is induced by progesterone and 17{beta}-estradiol. J Immunol 2009;183:759-69.
25. Sojka DK, Huang YH, Fowell DJ. Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target. Immunology 2008;124:13-22.
26. Curotto de Lafaille MA, Lafaille JJ. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 2009;30:626-35.
27. Janssens W, Carlier V, Wu B, VanderElst L, Jacquemin MG, Saint-Remy JM. CD4(+)CD25(+) T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner. J Immunol 2003;171:4604-12.
28. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005;6:338-44.
29. Rukavina D, Podack ER, Rubesa G, Spanjol-Pandelo S, Randic L. Down-regulated expression of perforin-positive/CD16+ cells in the peripheral blood lymphocytes in the first trimester of pregnancy and up-regulation at the end of pregnancy. Am J Reprod Immunol 1997;38:189-96.
30. Santoni A, Carlino C, Stabile H, Gismondi A. Mechanisms underlying recruitment and accumulation of decidual NK cells in uterus during pregnancy. Am J Reprod Immunol 2008;59:417-24.
31. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005;6:345-52.
32. Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 2003;112:1437-43.